Question 1

What is Rituximab?

Accepted Answer

Rituximab is a type of protein called a monoclonal antibody that is designed to recognize and bind to a specific target in the body. It works by attaching to the CD20 protein found on the surface of B-lymphocytes, which are a type of white blood cell.

Once attached, the medication helps the immune system identify and destroy these cells or prevents them from causing damage. This process is used to manage conditions where B-cells are growing uncontrollably or contributing to inflammation and tissue damage.

Question 2

What is Rituximab used for?

Accepted Answer

Rituximab is used to treat:

Non-Hodgkin lymphoma

Chronic lymphocytic leukemia

Rheumatoid arthritis

Others

Question 3

How does Rituximab work?

Accepted Answer

Targeting B-cells

Rituximab is a type of protein called a monoclonal antibody. It is engineered to recognize and bind to a specific marker known as CD20, which is found on the surface of B-lymphocytes (B-cells).

B-cells are white blood cells that play a key role in the immune system. In some conditions, these cells can become cancerous or may begin to attack the body's own healthy tissues. When rituximab attaches to the CD20 marker on these cells, it signals the body's immune system to attack and destroy them.

Effects on Disease

By lowering the number of B-cells, rituximab helps treat different types of illnesses:

Cancer: In certain blood cancers, it helps the immune system eliminate malignant B-cells to slow or stop the disease.

Autoimmune Conditions: In diseases like rheumatoid arthritis, it reduces the B-cells that contribute to inflammation and tissue damage.

The medication specifically targets cells expressing the CD20 protein, which allows it to focus on B-cells while leaving other types of immune cells alone.

Question 4

What are the brand names for Rituximab?

Accepted Answer

Rituximab is sold under the brand names Rituxan , MabThera , and Truxima .

Question 5

What are the active ingredients in Rituximab?

Accepted Answer

The active ingredient in Rituximab is rituximab .

Question 6

What are the side effects of Rituximab?

Accepted Answer

Common side effects of Rituximab may include:

infusion reactions

fever

chills

and others

Always consult with a healthcare professional about potential side effects.

Question 7

What drug class is Rituximab?

Accepted Answer

Rituximab belongs to the anti-CD20 monoclonal antibody drug class.

Question 8

What is the dosage of Rituximab and how do I take it?

Accepted Answer

Administration Methods

Rituximab is typically given as an infusion into a vein by a healthcare provider in a hospital or clinic setting. Some forms of the medication may also be given as an injection under the skin.

Treatment Schedule

The frequency of treatments varies based on the medical condition and how the patient responds to the drug. It may be given once a week for several weeks or at longer intervals, such as every few months.

Pre-medication and Monitoring

Before receiving rituximab, patients are often given other medications to help prevent or lessen potential infusion reactions. These may include:

Pain relievers or fever reducers

Antihistamines

Steroid medications

Healthcare providers will monitor the patient closely during and for a period after the administration to check for any immediate side effects or reactions.

Missed Doses

Because this medication is administered by a healthcare professional, it is important to keep all scheduled appointments. If an appointment is missed, contact the healthcare provider as soon as possible to reschedule the treatment.

Question 9

Is Rituximab safe during pregnancy and breastfeeding?

Accepted Answer

Pregnancy

Rituximab can cross the placenta and may affect the immune system of a developing fetus. Specifically, it may lead to a decrease in B-cells, which are a type of white blood cell, in the newborn. It is important to notify a healthcare provider immediately if you are pregnant or planning to become pregnant before starting this medication.

Contraception

Because of the potential risks to a fetus, healthcare providers typically recommend using effective birth control during treatment. This contraception should be continued for at least 12 months after the final dose of rituximab.

Breastfeeding

It is currently unknown if rituximab passes into human breast milk. Due to the risk of serious side effects in a nursing infant, breastfeeding is generally not recommended while receiving rituximab and for at least 6 months after the last dose. Patients should discuss the risks and benefits of breastfeeding with their medical team.

Question 10

What forms and strengths does Rituximab come in?

Accepted Answer

Rituximab is supplied as a liquid solution for use by medical professionals. It is available in two primary forms:

Intravenous Infusion: This form is injected directly into a vein. The first dose is usually given slowly over several hours to monitor for reactions.

Subcutaneous Injection: This form is injected into the tissue under the skin, typically in the abdominal area. It is often used after a patient has already received at least one dose through a vein.

The medication is provided in single-dose vials of varying concentrations. Your healthcare provider will determine the appropriate dose based on your body size and the specific condition being treated.

Question 11

What is the FDA approval status of Rituximab?

Accepted Answer

FDA Approval and Indications

Rituximab is approved by the U.S. Food and Drug Administration (FDA) for the treatment of several conditions, including:

Non-Hodgkin's lymphoma (NHL)

Chronic lymphocytic leukemia (CLL)

Rheumatoid arthritis (in combination with methotrexate)

Granulomatosis with polyangiitis (GPA) and Microscopic polyangiitis (MPA)

Moderate to severe pemphigus vulgaris

The medication is available as the original reference product and as several FDA-approved biosimilars. It is administered via intravenous infusion, though some formulations combined with hyaluronidase are approved for subcutaneous injection for specific indications.

Boxed Warnings

The FDA requires a boxed warning for rituximab because of the risk of severe and potentially fatal adverse reactions. These include:

Infusion-related reactions: Severe and fatal reactions have occurred, typically during the first infusion.

Severe mucocutaneous reactions: These include Stevens-Johnson syndrome and toxic epidermal necrolysis, which can be fatal.

Hepatitis B virus (HBV) reactivation: The FDA has issued safety communications requiring healthcare providers to screen all patients for HBV infection before starting treatment. Reactivation can lead to fulminant hepatitis, hepatic failure, and death.

Progressive multifocal leukoencephalopathy (PML): This is a rare, serious, and often fatal viral infection of the brain caused by the JC virus.

Question 12

What should I know about Rituximab and infusion?

Accepted Answer

Administration Process

Rituximab is administered by a healthcare professional in a medical setting, such as a hospital or infusion center. It is typically given as an intravenous (IV) infusion into a vein. Some versions of the medication may be given as a subcutaneous injection under the skin, usually in the abdominal area.

The first infusion is usually given slowly to monitor for any adverse reactions. If the patient tolerates the initial treatment well, future infusions may be administered at a faster rate.

Premedication

To help prevent or lessen the severity of infusion reactions, healthcare providers usually give other medications approximately 30 to 60 minutes before the rituximab treatment begins. These premedications often include:

Acetaminophen to reduce the risk of fever.

Antihistamines to help prevent allergic reactions.

Steroids to decrease inflammation.

Monitoring During and After Infusion

Medical staff will monitor vital signs, including blood pressure and heart rate, throughout the procedure. Monitoring typically continues for at least 15 to 30 minutes after the infusion is complete. Patients should notify their healthcare provider immediately if they experience any of the following during or after the treatment:

Fever, chills, or shivering

Itching, hives, or skin rash

Difficulty breathing, wheezing, or shortness of breath

Dizziness, lightheadedness, or fainting

Chest pain or a racing heartbeat

Swelling of the face, lips, tongue, or throat

Rituximab

Medication Quick Facts

📋Overview

What It's Used For

How It Works

Brand Names

Side Effects

Warnings & Precautions

Dosage & How to Take

Pregnancy & Breastfeeding

Forms & Strengths

FDA / Regulatory Status

Infusion Information

FAQ

Additional Resources

Support & Help Resources

Found an Error?